Medication info
Lobaro 2 mg (Pitavastatin Calcium)

Lobaro 2 mg (Pitavastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
Korea Hyoutech Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet with a score line.
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201502462 · Approved 2015.04.27 · Insurance code 649102690

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Before and during treatment with this drug, patients must follow a standard cholesterol-lowering diet. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams per day. The dose may be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. The therapeutic effect of this drug is maintained with continued administration.

Ingredients

Manufacturer
Korea Hyoutech Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

View approved original text

This medication helps to improve blood lipid levels in patients with primary hypercholesterolemia and mixed dyslipidemia. Specifically, it reduces total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels, while increasing HDL cholesterol levels to support cardiovascular health. This medication is used in conjunction with dietary measures to effectively control abnormal blood lipid levels.

How to take

Adult dose

Before and during treatment with this drug, patients must follow a standard cholesterol-lowering diet. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams per day. The dose may be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. The therapeutic effect of this drug is maintained with continued administration.

Precautions

This drug should not be used in patients who are allergic to certain ingredients or have liver disease, severe liver dysfunction or cholestasis, those taking cyclosporine, patients with myopathies, pregnant or potentially pregnant women, breastfeeding mothers, and patients with lactose intolerance. Caution should be exercised in patients with renal impairment or a history of liver disease, those who consume large amounts of alcohol, patients on fibrates or niacin, hypothyroid patients, elderly individuals, and patients with severe myasthenia gravis. Muscle pain, muscle weakness, abdominal pain, rash, pruritus, and other abnormal reactions may occur during treatment with this drug, and liver function and muscle condition should be regularly monitored. If muscle-related symptoms or abnormal findings are detected in blood tests, it may be necessary to immediately consult a physician and discontinue use. Since this medication is primarily metabolized in the liver, dosage adjustment may be necessary for patients with reduced liver function, and regular liver function tests are required. Additionally, this drug may interact with certain medications, and serious side effects may occur when taken with cyclosporine, fibrates, niacin, erythromycin, etc., so co-administration should be avoided or conducted with caution. Due to declining bodily functions, elderly patients may experience abnormal reactions more easily, necessitating caution during use. Pregnant women and nursing mothers should avoid this medication due to risks to the fetus and newborn, and women of childbearing potential should also refrain from using it. The safety and efficacy of this drug have not been established in children, and usage is therefore not recommended. Store the medication out of reach of children, and keep it in the original container to prevent quality degradation or misuse. Lastly, since this medication is used for the treatment of hypercholesterolemia, non-pharmacological treatments such as diet and exercise therapy should be considered prior to administration, and therapeutic effects should be monitored with discontinuation as necessary.

Side effects

  • Abdominal pain
  • rash
  • lethargy
  • paralysis
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute kidney failure
Show 99 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • dry mouth
  • dyspepsia
  • abdominal distention
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • neutropenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • frequent urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • weakness
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • elevated serum potassium and phosphorus
  • taste abnormalities
  • lethargy
  • positive antinuclear antibody
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • oculomotor weakness
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • dizziness
  • skin paresthesia
  • insomnia
  • sleep disorders
  • appetite loss
  • elevated blood pressure
  • discomfort in the chest
  • weakness
  • abdominal pain
  • dyspepsia
  • dry mouth
  • constipation
  • nausea
  • increased γ-GT
  • increased LDH
  • increased ALP
  • itching
  • urticaria
  • thrombocytopenia
  • elevated blood creatinine
  • increased BUN
  • elevated blood pressure
  • skin paresthesia
  • discomfort in the chest

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that does not allow light in. It is also recommended to store it at room temperature, between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's efficacy.

Appearance and packaging

Appearance

White round film-coated tablet with a score line.

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.